Evaluation of clopidogrel, hypercoagulability, and platelet count in dogs undergoing splenectomy for splenic masses

Dogs that had splenectomy are predisposed to fatal thrombotic conditions, and thrombocytosis is a risk factor for post-splenectomy hypercoagulability. However, in veterinary medicine, there are no specific therapeutic approaches for managing this hypercoagulability. This study aimed to determine the...

Full description

Saved in:
Bibliographic Details
Main Authors: Guk-Il Joung, Jeong-Yeol Bae, Jung-Il Kim, Jin-Young Kim, Joong-Hyun Song
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Veterinary Quarterly
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/01652176.2024.2347926
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846142130663194624
author Guk-Il Joung
Jeong-Yeol Bae
Jung-Il Kim
Jin-Young Kim
Joong-Hyun Song
author_facet Guk-Il Joung
Jeong-Yeol Bae
Jung-Il Kim
Jin-Young Kim
Joong-Hyun Song
author_sort Guk-Il Joung
collection DOAJ
description Dogs that had splenectomy are predisposed to fatal thrombotic conditions, and thrombocytosis is a risk factor for post-splenectomy hypercoagulability. However, in veterinary medicine, there are no specific therapeutic approaches for managing this hypercoagulability. This study aimed to determine the preventive effect of clopidogrel on post-operative hypercoagulability during the first 2 weeks post-splenectomy in dogs with splenic masses. This study included 12 dogs that had splenectomy. Seven dogs received no treatment (group A), and five were treated with clopidogrel (group B). Clopidogrel was loaded at 10 mg/kg on day 2 and continued at 2 mg/kg until day 14. Blood samples were collected on the day of surgery and 2, 7, and 14 days after splenectomy in both groups. In group B, thromboelastography (TEG) was performed on the same days. In group A, there was significant elevation of platelet counts on days 7 (p = 0.007) and 14 (p = 0.001) compared to day 0. In group B, the platelet counts were significantly elevated on day 7 (p = 0.032) but no significant difference was found on day 14 compared to day 0. Platelet counts on day 14 were significantly higher in group A than in group B (p = 0.03). The lower platelet counts were correlated with alterations in TEG parameters, and no significant differences were found in the K and α-angle values at all postoperative assessment points compared to day 0. Our study suggests that clopidogrel may reduce post-operative thrombocytosis and hypercoagulability in dogs that undergo splenectomy for splenic masses.
format Article
id doaj-art-869b0d0ddec74991baeb227eaa6a16f6
institution Kabale University
issn 0165-2176
1875-5941
language English
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series Veterinary Quarterly
spelling doaj-art-869b0d0ddec74991baeb227eaa6a16f62024-12-03T17:25:18ZengTaylor & Francis GroupVeterinary Quarterly0165-21761875-59412024-12-014411810.1080/01652176.2024.2347926Evaluation of clopidogrel, hypercoagulability, and platelet count in dogs undergoing splenectomy for splenic massesGuk-Il Joung0Jeong-Yeol Bae1Jung-Il Kim2Jin-Young Kim3Joong-Hyun Song4Department of Veterinary Internal Medicine, College of Veterinary Medicine, Chungnam National University, Daejeon, South KoreaDepartment of Veterinary Internal Medicine, College of Veterinary Medicine, Chungnam National University, Daejeon, South KoreaDepartment of Veterinary Internal Medicine, College of Veterinary Medicine, Chungnam National University, Daejeon, South KoreaDepartment of Veterinary Internal Medicine, College of Veterinary Medicine, Chungnam National University, Daejeon, South KoreaDepartment of Veterinary Internal Medicine, College of Veterinary Medicine, Chungnam National University, Daejeon, South KoreaDogs that had splenectomy are predisposed to fatal thrombotic conditions, and thrombocytosis is a risk factor for post-splenectomy hypercoagulability. However, in veterinary medicine, there are no specific therapeutic approaches for managing this hypercoagulability. This study aimed to determine the preventive effect of clopidogrel on post-operative hypercoagulability during the first 2 weeks post-splenectomy in dogs with splenic masses. This study included 12 dogs that had splenectomy. Seven dogs received no treatment (group A), and five were treated with clopidogrel (group B). Clopidogrel was loaded at 10 mg/kg on day 2 and continued at 2 mg/kg until day 14. Blood samples were collected on the day of surgery and 2, 7, and 14 days after splenectomy in both groups. In group B, thromboelastography (TEG) was performed on the same days. In group A, there was significant elevation of platelet counts on days 7 (p = 0.007) and 14 (p = 0.001) compared to day 0. In group B, the platelet counts were significantly elevated on day 7 (p = 0.032) but no significant difference was found on day 14 compared to day 0. Platelet counts on day 14 were significantly higher in group A than in group B (p = 0.03). The lower platelet counts were correlated with alterations in TEG parameters, and no significant differences were found in the K and α-angle values at all postoperative assessment points compared to day 0. Our study suggests that clopidogrel may reduce post-operative thrombocytosis and hypercoagulability in dogs that undergo splenectomy for splenic masses.https://www.tandfonline.com/doi/10.1080/01652176.2024.2347926Clopidogreldoghypercoagulabilitysplenectomythrombocytosis
spellingShingle Guk-Il Joung
Jeong-Yeol Bae
Jung-Il Kim
Jin-Young Kim
Joong-Hyun Song
Evaluation of clopidogrel, hypercoagulability, and platelet count in dogs undergoing splenectomy for splenic masses
Veterinary Quarterly
Clopidogrel
dog
hypercoagulability
splenectomy
thrombocytosis
title Evaluation of clopidogrel, hypercoagulability, and platelet count in dogs undergoing splenectomy for splenic masses
title_full Evaluation of clopidogrel, hypercoagulability, and platelet count in dogs undergoing splenectomy for splenic masses
title_fullStr Evaluation of clopidogrel, hypercoagulability, and platelet count in dogs undergoing splenectomy for splenic masses
title_full_unstemmed Evaluation of clopidogrel, hypercoagulability, and platelet count in dogs undergoing splenectomy for splenic masses
title_short Evaluation of clopidogrel, hypercoagulability, and platelet count in dogs undergoing splenectomy for splenic masses
title_sort evaluation of clopidogrel hypercoagulability and platelet count in dogs undergoing splenectomy for splenic masses
topic Clopidogrel
dog
hypercoagulability
splenectomy
thrombocytosis
url https://www.tandfonline.com/doi/10.1080/01652176.2024.2347926
work_keys_str_mv AT gukiljoung evaluationofclopidogrelhypercoagulabilityandplateletcountindogsundergoingsplenectomyforsplenicmasses
AT jeongyeolbae evaluationofclopidogrelhypercoagulabilityandplateletcountindogsundergoingsplenectomyforsplenicmasses
AT jungilkim evaluationofclopidogrelhypercoagulabilityandplateletcountindogsundergoingsplenectomyforsplenicmasses
AT jinyoungkim evaluationofclopidogrelhypercoagulabilityandplateletcountindogsundergoingsplenectomyforsplenicmasses
AT joonghyunsong evaluationofclopidogrelhypercoagulabilityandplateletcountindogsundergoingsplenectomyforsplenicmasses